双鹭药业：GLP-1长效产品正在整理资料准备上报

Core Viewpoint - The company is preparing to submit documentation for its long-acting GLP-1 product, indicating progress in its development pipeline [1] Group 1 - The company announced on November 3 that it is organizing materials for submission regarding its GLP-1 long-acting product [1]